why choose us

First received: January 20, 2023

Clinical Trial: Arrythmia Burden in Cardiac Contractility Modulation (CCM)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atrial Fibrillation

Study Type: OBSERVATIONAL


Official Title: Arrhythmia Burden in Patients With Impulse Dynamics Optimizer Cardiac Contractility Modulation (CCM) Device Implantation: Retrospective and Prospective Evaluation

Brief Summary: The Impulse Dynamics Optimizer Device is a Food and Drug Administration (FDA) approved; commercially available device indicated for patients with heart failure with reduced ejection fraction (HFrEF).Many candidates of this device have a previously implanted cardiovascular implantable electronic device (CIED)- internal cardioverter defibrillator (ICD) or permanent pacemaker (PM).Patients with heart failure are at high risk for both atrial and ventricular cardiac arrhythmias.The aim of this study is to evaluate…

Read more